Wockhardt Limited
Mirae Asset Mutual Fund has disappeared from Wockhardt Limited's latest shareholder list, down from a 1.03 percent stake. This indicates Mirae Asset Mutual Fund has either fully exited the position or trimmed it below the 1 percent disclosure threshold.
A global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals, and topicals for diverse therapeutic applications. Wockhardt operates across multiple segments, serving domestic and international markets with a comprehensive product portfolio spanning conventional pharmaceuticals and advanced biopharmaceutical solutions. The company distinguishes itself through vertically integrated operations and a focus on both established and emerging therapeutic areas.
Indian arm of South Korea's Mirae Asset Global Investments, one of Asia's largest asset managers. Manages over Rs 2.5 lakh crore in India across equity and hybrid funds. CIO Neelesh Surana has built a reputation for rigorous bottom-up stock selection with a long-term quality growth bias. Mirae Asset Emerging Bluechip Fund built a cult following before being closed to fresh investments due to size.